Acer therapeutics investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of acer therapeutics inc. - acer

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of acer therapeutics inc. (nasdaqcm: acer) to zevra therapeutics, inc. (nasdaqgs: zvra). under the terms of the proposed transaction, shareholders of acer will receive 0.121 shares of zevra for each share of acer that they own. additionally, acer stockholders would receive non-transferable contingent value rights.
ACER Ratings Summary
ACER Quant Ranking